Association between the atherogenic index of plasma and incident hypertension across different blood pressure states: a national cohort study
- PMID: 40399995
- PMCID: PMC12093804
- DOI: 10.1186/s12933-025-02775-9
Association between the atherogenic index of plasma and incident hypertension across different blood pressure states: a national cohort study
Abstract
Background: Hypertension is a major public health concern, making effective preventive strategies essential. The atherogenic index of plasma (AIP), a new lipid metabolic index that is associated with insulin resistance and cardiovascular diseases. However, the association between AIP and the incidence of hypertension remains unexplored. To address this knowledge gap, we designed a large-scale retrospective cohort study to investigate the association between AIP and the occurrence of hypertension across different blood pressure (BP) states, including individuals with normal BP and those with elevated BP.
Methods: This retrospective cohort study used data from the China Health and Retirement Longitudinal Study (CHARLS) involving participants aged 45 and older, assessed in 2011 and followed up in 2020. AIP was calculated using the logarithmic ratio of triglycerides (TG) to high-density lipoprotein cholesterol (HDL-C). Logistic regression models, restricted cubic splines models, and threshold analyses were employed to examine the relationship between AIP and the incidence of hypertension. Receiver Operating Characteristic analysis was utilized to assess the ability of AIP to predict the incidence of hypertension. Subgroup analyses were conducted across various demographic and health-related factors. Sensitivity analyses were employed to address biases arising from self-reported data.
Results: Among 6540 participants, 1909 (29.19%) developed hypertension over nine years. The AIP is an independent risk factor for the development of hypertension, with an adjusted odds ratio of 1.84 [95% confidence interval (CI) 1.41-2.39, p < 0.001] in individuals with normal BP and 1.88 (95% CI 1.40-2.52, p < 0.001) in those with elevated BP. A nonlinear relationship between AIP and the incidence of hypertension was identified in both normal BP and elevated BP population. AIP has a better predictive ability for the occurrence of hypertension compared to the single indicators of TG and HDL-C. Age significantly impacted AIP's predictive value, especially in those aged 45 to 60 in normal BP population. Sensitivity analyses further validated the nonlinear relationship between AIP and the occurrence of hypertension.
Conclusions: AIP is a significant predictor of hypertension, demonstrating a nonlinear association with its occurrence in normal BP and elevated BP population.
Trial registration: Not applicable.
Keywords: Atherogenic index of plasma; CHARLS; Elevated blood pressure; Hypertension; Risk assessment.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The CHARLS study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Peking University (IRB00001052-11015). All participants provided written informed consent before participating in the CHARLS study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures








References
-
- Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE million persons project). Lancet. 2017;390:2549–58. - PubMed
-
- McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912–4018. - PubMed
-
- Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circ Res. 2023;132:1050–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous